2022
DOI: 10.3389/fnut.2022.978110
|View full text |Cite
|
Sign up to set email alerts
|

Association between sarcopenia and prognosis of hepatocellular carcinoma: A systematic review and meta-analysis

Abstract: BackgroundSarcopenia, characterized by the loss of muscle mass, strength, and physical ability, occurs with aging and certain chronic illnesses such as chronic liver diseases and cancer. Sarcopenia is common in liver cirrhosis and hepatocellular carcinoma (HCC). Previous reports of association between sarcopenia and prognosis of HCC have been inconsistent. Therefore, the present systematic review and meta-analysis aimed to investigate the impact of sarcopenia on the survival of patients with HCC.MethodsA syste… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 88 publications
1
10
0
Order By: Relevance
“…The mechanism is complex, but it is well established that chronic liver disease can trigger muscle atrophy and structural changes in skeletal muscle, and skeletal muscle compartments contribute to the progression of liver disease (20). In addition, muscle loss leads to insulin resistance and increases the activity of IGF-1, which can regulate hepatocyte proliferation (21).…”
Section: Discussionmentioning
confidence: 99%
“…The mechanism is complex, but it is well established that chronic liver disease can trigger muscle atrophy and structural changes in skeletal muscle, and skeletal muscle compartments contribute to the progression of liver disease (20). In addition, muscle loss leads to insulin resistance and increases the activity of IGF-1, which can regulate hepatocyte proliferation (21).…”
Section: Discussionmentioning
confidence: 99%
“…Up to 30%-40% of HCC patients are affected by sarcopenia at the time of diagnosis, at least partially because of the pro-inflammatory state triggered by the altered tumor microenvironment[ 45 ]. As sarcopenia influences the response to surgical, locoregional, and systemic treatments, its timely recognition is essential.…”
Section: Prevalence and Role Of Sarcopenia Across Liver Diseasesmentioning
confidence: 99%
“…Each domain was judged as low, moderate, or high risk of bias, according to published criteria [17]. The overall risk of bias for an included study was defined as low risk with ≥ 4 low-and no high-risk domains, moderate risk with < 4 low-and no highrisk domains, and high risk with ≥ 1 high-risk domain [18].…”
Section: Assessment Of Risk Of Biasmentioning
confidence: 99%